Matzku S, Rapp W
Biochim Biophys Acta. 1976 Sep 28;446(1):30-40. doi: 10.1016/0005-2795(76)90094-5.
The pepsinogen II group was prepared from gastric mucosal extract by a two-step procedure consisting of immunoadsorption to an anti-pepsinogen II column, followed by ion exchange chromatography on DEAE-Sephadex A-50. The final product was pure according to biochemical and immunochemical criteria. As determined by quantitative immunodiffusion, the enrichment factor of pepsinogen II was 34. A recovery of 55% was calculated. The effectiveness of this procedure was due to the use of purified anti-pepsinogen II antibodies for immunoadsorption. This was achieved by immunoadsorption to Sepharose bound crude pepsinogen and a further passage over an unrelated immunoadsorbent (human serum coupled to Sepharose). The immunoadsorbent prepared using purified anti-pepsinogen antibodies showed low non-biospecific binding of gastric extract proteins. Complete separation of pepsinogen II from pepsinogen I was observed in one single passage. Purified pepsinogen II showed two protein bands in polyacrylamide gel electrophoresis and four bands of proteolytic activity in agarose enzyme electrophoresis. In both methods, as well as in two-dimensional immunoelectrophoresis, components with the same electrophoretic mobility were detected in pure preparations of group and II pepsinogens. Consequently, only in pure preparations was it possible to define the exact number of bands belonging to each of the two groups and to assess the immunological specificity of every band. Upon hydroxyapatite chromatography purified pepsinogen II was further resolved into two fractions.
胃蛋白酶原II组是通过两步法从胃黏膜提取物中制备的,第一步是免疫吸附到抗胃蛋白酶原II柱上,然后在DEAE-葡聚糖A-50上进行离子交换色谱。根据生化和免疫化学标准,最终产物是纯的。通过定量免疫扩散测定,胃蛋白酶原II的富集因子为34。计算回收率为55%。该方法的有效性归因于使用纯化的抗胃蛋白酶原II抗体进行免疫吸附。这是通过将粗胃蛋白酶原免疫吸附到琼脂糖上,并进一步通过无关的免疫吸附剂(与人血清偶联的琼脂糖)来实现的。使用纯化的抗胃蛋白酶原抗体制备的免疫吸附剂对胃提取物蛋白的非生物特异性结合较低。在单次通过中观察到胃蛋白酶原II与胃蛋白酶原I完全分离。纯化的胃蛋白酶原II在聚丙烯酰胺凝胶电泳中显示出两条蛋白带,在琼脂糖酶电泳中显示出四条蛋白水解活性带。在这两种方法以及二维免疫电泳中,在胃蛋白酶原II组的纯制剂中检测到具有相同电泳迁移率的成分。因此,只有在纯制剂中才能确定属于两组中每组的条带的确切数量,并评估每条带的免疫特异性。经羟基磷灰石色谱法,纯化的胃蛋白酶原II进一步分离成两个组分。